[[{“value”:”
Health officials in France recently extended the country’s experimental medical cannabis program for another six months, RFI reports.
The rules were set to expire on December 31, 2024, but officials extended the experiment until July 31, 2025. The departing health minister Geneviève Darrieussecq wrote in a letter that the agency enacted the extension “with a view to weaning patients off the drug or finding alternatives,” the report said.
Health officials rolled out the program in March 2021, involving at launch 3,000 patients with chronic diseases and specialist physicians in pain, oncology, neurology, epilepsy, multiple sclerosis, and palliative care. The government’s plan for the program was to study the effects of medical cannabis and its derivatives.
Outside of the program, cannabis remains strictly prohibited in France. Shops selling low-THC, CBD-rich hemp flower products, however, are active in many parts of the country. The government had enacted a ban on the possession, use, and sale of CBD products in December 2021 but just one month later, the Constitutional Council of France ruled that CBD is not addictive or harmful, overturning the ban.
On Wednesday, the new French Health Minister Yannick Neuder said he supports studying medical cannabis but remains opposed to adult-use legalization, The Local reports.
In 2020, several dozen French MPs penned a letter decrying efforts to legalize adult-use cannabis.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Perspective to add? Suggest a revision or submit commentary for review using the form below.
Note: our editors approve comments that provide new and succinct insight to our audience. If your comment is chosen for publishing, it will appear at the end of the article along with your name, job title, and organization. If you have a profile in the Ganjapreneur Business Index, your comment will also include a backlink for reference. If you are suggesting a correction, we will look into the issue further.
Based in Portland, Oregon, Graham is Ganjapreneur’s Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in 2014.
Ganjapreneur is made possible by our partners:
“}]] [[{“value”:”Health officials in France recently extended the country’s experimental medical cannabis program for another six months, RFI reports.
The rules were set to expire on December 31, 2024, but officials extended the experiment until July 31, 2025. The departing health minister Geneviève Darrieussecq”}]] Read More
